IP Library Granted Patent US 10,518,082
Granted Patent B2
US 10,518,082 · App. 15/700,013 · Granted Dec 31, 2019

Methods and systems for treating hypertension using an implantable electroacupuncture device

Inventors: Jeffrey H. Greiner (Valencia, CA); David K. L. Peterson (Valencia, CA); Chuladatta Thenuwara (Valencia, CA)
Assignee: Valencia Technologies Corporation
A61N1/0504A61H39/002A61N1/36117A61N1/36175A61N1/3756A61N1/37205A61H2201/5005A61H2201/5035A61H2201/5038A61H2201/5097A61N1/3605A61N1/36125A61N1/3758A61N1/3782Y10S128/907
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,518,082
App. No.
15/700,013
Granted
Dec 31, 2019
Kind
B2
Abstract

An electroacupuncture device for treating hypertension in a patient includes 1) a housing configured to be implanted beneath a skin surface of the patient at an acupoint corresponding to a target tissue location within the patient, the acupoint comprising at least one of PC5, PC6, ST36, and ST37, 2) a central electrode of a first polarity and centrally located and substantially planar on a first surface of the housing, 3) an annular electrode of a second polarity and that surrounds the central electrode on the first surface of the housing, the annular electrode being spaced apart from the central electrode, and 4) pulse generation circuitry located within the housing and electrically coupled to the annular and central electrodes.

Claims (39)

1. An electroacupuncture device for treating hypertension in a patient, comprising:

a housing configured to be implanted beneath a skin surface of the patient at an acupoint corresponding to a target tissue location within the patient, the acupoint comprising at least one of PC5, PC6, ST36, and ST37;

a central electrode of a first polarity and centrally located and substantially planar on a first surface of the housing;

an annular electrode of a second polarity and that surrounds the central electrode on the first surface of the housing, the annular electrode being spaced apart from the central electrode; and

pulse generation circuitry located within the housing and electrically coupled to the annular and central electrodes, wherein the pulse generation circuitry

generates stimulation sessions at a duty cycle that is less than 0.05, and

applies the stimulation sessions to the target tissue location by way of the central electrode and the annular electrode in accordance with the duty cycle,

wherein

each stimulation session included in the plurality of stimulation sessions comprises a series of stimulation pulses,

the duty cycle is a ratio of T 3 to T 4 , and

each stimulation session included in the stimulation sessions has a duration of T 3 minutes and occurs at a rate of once every T 4 minutes.

2. The electroacupuncture device of claim 1 , wherein the target tissue location is a median nerve of the patient.

3. The electroacupuncture device of claim 1 , wherein the stimulation sessions are configured to reduce sympathetic activity within the patient.

4. The electroacupuncture device of claim 1 , wherein T 3 is at least 10 minutes and less than 60 minutes, and wherein T 4 is at least 1440 minutes.

5. The electroacupuncture device of claim 1 , further comprising a magnetic sensor that receives, from a device external to the electroacupuncture device, a control command that configures the electroacupuncture device for treating hypertension.

6. The electroacupuncture device of claim 5 , wherein the magnetic sensor receives the control command by detecting a magnetic field generated by the device external to the electroacupuncture device.

7. The electroacupuncture device of claim 1 , further comprising a battery that powers the pulse generation circuitry, the battery having an internal impedance of at least 5 ohms.

8. The electroacupuncture device of claim 7 , wherein the battery is non-rechargeable.

9. The electroacupuncture device of claim 7 , wherein the battery has a capacity of less than 60 mAh.

10. The electroacupuncture device of claim 1 , wherein the housing is coin-sized and coin-shaped.

11. The electroacupuncture device of claim 1 , wherein the annular electrode is located on the first surface of the housing.

12. The electroacupuncture device of claim 1 , wherein the annular electrode comprises a ring electrode located around a perimeter edge of the housing.

13. The electroacupuncture device of claim 1 , wherein the annular electrode surrounds the central electrode and is spaced at least 5 mm from a center of the central electrode.

14. The electroacupuncture device of claim 1 , wherein the pulse generation circuitry applies the stimulation sessions to the target tissue location by applying the stimulation sessions by way an electrode included on a lead connected to the electroacupuncture device.

15. A system for treating hypertension in a patient, comprising:

a housing configured to be implanted beneath a skin surface of the patient at an acupoint corresponding to a target tissue location within the patient the acupoint comprising at least one of PC5, PC6, ST36, and ST37;

a central electrode of a first polarity and centrally located and substantially planar on a first surface of the housing;

an annular electrode of a second polarity and that surrounds the central electrode on the first surface of the housing, the annular electrode being spaced apart from the central electrode;

means for generating stimulation sessions at a duty cycle that is less than 0.05; and

means for applying the stimulation sessions to the target tissue location by way of the central electrode and the annular electrode in accordance with the duty cycle,

wherein

each stimulation session included in the plurality of stimulation sessions comprises a series of stimulation pulses,

the duty cycle is a ratio of T 3 to T 4 , and

each stimulation session included in the stimulation sessions has a duration of T 3 minutes and occurs at a rate of once every T 4 minutes.

16. The system of claim 15 , wherein the target tissue location is a median nerve of the patient.

17. The system of claim 15 , further comprising a battery that powers the pulse generation circuitry, the battery having an internal impedance of at least 5 ohms.

18. The system of claim 17 , wherein the battery is non-rechargeable.

19. The system of claim 17 , wherein the battery has a capacity of less than 60 mAh.

20. The system of claim 15 , wherein the housing is coin-sized and coin-shaped.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded May 6, 2026
From: MEDTRONIC, INC.
To: VALENCIA BIOSCIENCE, INC.
Reel/Frame 075721/0223 →
SECURITY INTEREST Recorded Oct 27, 2023
From: VALENCIA BIOSCIENCE, INC.
To: MEDTRONIC, INC.
Reel/Frame 065382/0738 →
SECURITY INTEREST Recorded Aug 4, 2021
From: VALENCIA BIOSCIENCE, INC.
To: MEDTRONIC, INC.
Reel/Frame 057088/0352 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 3, 2020
From: VALENCIA TECHNOLOGIES CORPORATION
To: VALENCIA BIOSCIENCE, INC.
Reel/Frame 053684/0656 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 8, 2017
From: GREINER, JEFFREY H.; PETERSON, DAVID K. L.; THENUWARA, CHULADATTA
To: VALENCIA TECHNOLOGIES CORPORATION
Reel/Frame 043538/0926 →
Continuity (11)
Division 14805355 · Jul 21, 2015
Continuation 14446500 · Jul 30, 2014
Division 13598575 · Aug 29, 2012
Provisional Application 61575869 · Aug 30, 2011
Provisional Application 61606995 · Mar 6, 2012
Provisional Application 61609875 · Mar 12, 2012
Provisional Application 61672257 · Jul 16, 2012
Provisional Application 61672661 · Jul 17, 2012
Provisional Application 61674691 · Jul 23, 2012
Provisional Application 61676275 · Jul 26, 2012
Related Publication 20180021566A1 · Jan 25, 2018
Cited By (3)
US 12,194,307 US 12,527,955 US 12,605,542